Hennion & Walsh Asset Management, Inc.
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1861642
Parsippany, NJ
Position in SUPN
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$4,195,806
-$376,381 QoQ
Shares Held
90,213
+2.0% QoQ
Ownership
0.155%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#67
of 331 holders
Holding Since
Mar 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Hennion & Walsh Asset Management, Inc. holds $46,273,526 across 11 Drug Manufacturers - Specialty & Generic names. SUPN ranks #4 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
360,245 | $14,780,852 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
327,801 | $11,105,897 | |
| 3 | PCRX |
Pacira BioSciences, Inc.
|
203,520 | $5,163,302 | |
| 4 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
90,213 | $4,195,806 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
6,097 | $3,303,537 | |
| 6 | ALKS |
Alkermes plc.
|
47,317 | $2,479,174 | |
| 7 | VTRS |
Viatris Inc
|
104,642 | $1,661,714 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
|
112,893 | $1,128,930 |
All Filings in SUPN
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,195,806 | 90,213 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $4,572,187 | 88,454 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $4,008,354 | 80,651 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $4,862,154 | 101,740 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $2,989,388 | 94,841 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $2,541,727 | 77,610 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $2,397,624 | 66,306 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $1,287,796 | 41,302 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $1,135,510 | 42,449 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $1,359,078 | 39,844 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $672,536 | 23,239 | Shares | Sole | 2024-01-10 | |
| 2022-09-30 | $4,124,114 | 121,835 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,722,524 | 128,718 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $6,550,682 | 202,682 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $6,328,944 | 217,042 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,534,736 | 245,022 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $7,788,884 | 252,968 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $6,586,992 | 251,604 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||